Recent Security Class Actions

Marinus Pharmaceuticals Inc. Common Stock (NASDAQ: MRNS)

51 Days left to seek lead plaintiff status.

Company Name:Marinus Pharmaceuticals Inc. Common Stock
Stock Symbol:NASDAQ: MRNS
Class Period Start:03/17/2021
Class Period End (inclusive):05/07/2024
Filing Deadline:08/05/2024

The Complaint alleges that Defendants throughout the Class Period made materially false and/or misleading statements and/or failed to disclose that: (1) Defendants understated the risk of failure to meet the early-stopping criteria in the RAISE trial; (2) Defendants did not disclose that a possible consequence of failing to meet the early stopping criteria in the RAISE trial would be that Marinus would stop the separate Phase 3 RAISE II trial; and (3) as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all times.

Marinus Pharmaceuticals Inc. Common Stock (NASDAQ: MRNS) Claim Form

Name(Required)
Address
This field is for validation purposes and should be left unchanged.